Abiopharma

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest Change - JPMorgan Chase & Co.

General Announcement: Notification of Release of Interim Business Updates for the First Quarter Ended 31 March 2026

General Announcement: SUCCESSFUL CLOSE OF SANLI ENVIRONMENTALS 6M SERIES 002 CP ON ADDX DIGITAL SECURITIES PLATFORM

Change in holdings of interested parties/officers

Employee Stock Option/ Share Scheme: Grant of options pursuant to the Aztech Employee Share Option Scheme

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: CHANGE IN INTEREST OF DIRECTOR

General Announcement: SUCCESSFUL CLOSE OF SERIES 005 OF 6-MONTH DIGITAL SECURITIES COMMERCIAL PAPER ON THE SDAX PLATFORM

Request for Lifting of Trading Halt: LIFTING OF TRADING HALT

General Announcement: CEO INCREASES STAKE PRESS RELEASE

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: DISCLOSURE OF INTEREST OF DIRECTOR - NG YEW NAM

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: CHANGE IN INTEREST OF DIRECTOR

General Announcement: SUCCESSFUL CLOSE OF SERIES 012 OF 6-MONTH DIGITAL SECURITIES COMMERCIAL PAPER

Financial Statements and Related Announcement: First Quarter Results

General Announcement: ALLOTMENT AND ISSUANCE OF SHARES PURSUANT TO WARRANT EXERCISE

New Form 13F-NT - UBS AG <b>Filed:</b> 2026-05-06 <b>AccNo:</b> 0001114446-26-002838 <b>Size:</b> 2 KB